Insider Trading May 19, 2026 04:34 PM

Executive Transactions and Operational Updates at Alignment Healthcare

President Dawn Maroney sells shares under 10b5-1 plan; company reports strong Q1 earnings and leadership transitions.

By Jordan Park ALHC

Alignment Healthcare's President, Dawn Maroney, executed a sale of common stock totaling $482,565 on May 15, 2026. This transaction was conducted under a Rule 10b5-1 trading plan. Beyond the reported stock activity, the company disclosed positive first-quarter 2026 earnings that surpassed expectations and announced key leadership shifts.

Executive Transactions and Operational Updates at Alignment Healthcare
ALHC

Key Points

  • The reported share sale by executive Dawn Maroney indicates controlled divestiture under established trading guidelines.
  • Alignment Healthcare demonstrated robust financial performance in Q1 2026, with earnings per share significantly exceeding analyst projections.
  • The company announced structural changes in its leadership, solidifying roles for key executives following strategic adjustments.

The latest filings reveal significant insider activity at Alignment Healthcare, Inc. (NASDAQ:ALHC), particularly involving President Dawn Christine Maroney. On May 15, 2026, Ms. Maroney reported the divestiture of company common stock valued at $482,565. The transaction involved the sale of 30,000 shares, which were sold at a weighted-average price of $16.0855 per share. It is noted that these sales occurred under a Rule 10b5-1 trading plan, a mechanism adopted on May 22, 2025.

The individual sale prices for the shares ranged between $15.70 and $16.66. As of recent market reporting, ALHC stock was trading at $16.36, although the price had experienced an 11% decline over the preceding week.


In addition to the reported sale, Ms. Maroney also disclosed two gift transactions involving company common stock. On May 15, 2026, she gifted 1,500 shares to a family member. A subsequent transaction three days later, on May 18, 2026, saw an additional 20,000 shares gifted to a charitable donor-advised fund. Both of these gift transactions were reported at a price point of $0 per share.


Following all recorded activities, Ms. Maroney's direct ownership stake in Alignment Healthcare common stock totals 977,313 shares. From an analytical perspective, the company currently maintains a market capitalization of $3.39 billion and has been assigned a

Risks

  • Stock price volatility: The stock has declined by 11% over the past week, suggesting potential market headwinds or investor caution.
  • Reliance on executive plans: The sale was executed through a Rule 10b5-1 plan, which while structured, does not negate general market sentiment risk.
  • Market valuation perception: While the stock is assessed as undervalued by one analysis source based on its Fair Value assessment, external market movements and overall sector conditions could present unforeseen risks.

More from Insider Trading

Electromed Director Sells Shares Amid Company Gains and Q3 Financial Outperformance May 19, 2026 Duolingo Executive Sells Shares Despite Strong Fundamentals and Recent Earnings Beat May 19, 2026 Duolingo Executive Transactions and Stock Valuation Context May 19, 2026 Director Milton C. Ault III Acquires Shares in Universal Safety Products May 19, 2026 McGrath RentCorp Executive Selling Shares Amid Mixed Q1 Results and New Credit Facility May 19, 2026